HDAC5 and the Epigenetics of Addiction
Two new studies explain the role of the epigenetic enzyme, HDAC5, in cocaine addiction and depression.
Mavoglurant Effective Against Cocaine Addiction in Phase 2 Trial
The drug company, Novartis, reports a significant decline in cocaine use with mavoglurant in phase 2 trial.
Dr. Anna Lembke on Using GLP-1 Drugs to Treat Addiction
Stanford University psychiatrist, Dr. Anna Lembke, assesses the use of GLP-1 drugs for treating addictions.
The Impact of GLP-1 Drugs on Reward Pathways
We examine the impact of GLP-1 drugs such as Ozempic on reward pathways and the dopamine system.
Move Over Ozempic, Here Comes Petrelintide
Roche has signed a multi-billion dollar deal with Zealand Pharma to develop the weight loss drug petrelintide.
Can GLP-1 Drugs Treat Pornography Addiction?
A look at the scientific evidence on the use of GLP-1 drugs to treat problem sexual behaviors.